SRRK (SRRK) Stock Price & Analysis
SRRK (SRRK) fell 1.09% to USD 55.33 as of September 8, 2026 at 05:47 UTC, according to Nexqual real-time market data.
SRRK last closed at USD 55.33; the session ranged USD 55–55.86 on volume of 658,048 shares. Market capitalization is —, with a 52-week range of USD 27.07–61.76 (NMS). Source: Nexqual, September 8, 2026 at 05:47 UTC.
Key Statistics (as of September 8, 2026 at 05:47 UTC)
| Price | USD 55.33 |
|---|---|
| Change | ▼ 1.09% (down) |
| Previous Close | USD 55.33 |
| Open | USD 55.33 |
| Day Range | USD 55 – 55.86 |
| 52-Week Range | USD 27.07 – 61.76 |
| Volume | 658,048 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SRRK)
Nexqual's technical model rates SRRK "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:47 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.43 (neutral) |
| vs SMA50 | Above (USD 53.44) |
| MACD | 1.28 (positive) |
From SRRK's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| REPL | Replimune Group, Inc. | USD 15.04 | ▼ 5.88% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 102.74 | ▼ 2.54% |
| IDYA | IDEAYA Biosciences, Inc. | USD 39.86 | ▼ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:47 UTC. This page is informational and not investment advice.